Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Monday, June 29

P. ERSSSO S rckA113 -124,Tac 111-21

11232 Experimental transmission of SIVrcm isolated from red capped
mangabey to Macaque
Maria Makuwa*; M.C. Georges-Gourbot; C Y Lu; 6. Dubreuil;
PA.Marx; AJ. Georges, Gabon
11233 Abacavir (1592, ABC) prevents spread of HIV-1 in brain tissue
ofSCID mice with HIV-1 encephalitis
Jenae Limoges*; D.R. McClernon; Y. Persidsky;J. Rasmussen;
E.R. Lanier; J. Reinhard; H.E. Gendelman, USA
11234 Effects of glycyrrhizin on opportunistic Candida albicans infection in
MAIDS mice
Tokuichiro Utsunomiya*; M. Kobayashi; R.B. Pollard; M. Ito;
F Suzuki, USA
11235 Antifungal effects of lanoconazole on Cryptococcus neoformans,
(C. neoformans) infection in MAIDS mice
Fujio Suzuki*; K. Furukawa; H. Sasaki; R.B. Pollard, USA
11236 A prospective, controlled study to evaluate the effect of an essential
sterol and sterolin formulation as a putative immune modulator in FIV
(feline immunodeficiency virus) infected laboratory cats
Johan Lamprecht*; P. Bouic; M. Freestone; M. Austin, South Africa
11237 Evaluation of the corneal endothelium in rabbits treated
with subconjunctival ganciclovir (DHPG)
Maria De Lourdes Veronese Rodrigues*; M. Saad Avila Morales;
L. Ventura; 5.J. Faria Esousa; J. Coutinh 0 Neto; N. V. Souza;
J.F Castro Figueiredo, Brazil
11238 Attenuated SIVVaccines:Safety and efficacy following
heterologous challenge
Mark G. Lewis*; F. Novembre; R. Desrosiers; Y. Lu; E. Rud;
V Hirsch; D. Birx, USA
11239 Role of b-chemokines in protective immunity against intrarectal
SIVsm challenge of macaques
Rigmor Thorstensson*; R. Ahmed; C Wilson; P. Putkonen;
Y Wang; T Lehner; G. Biberfeld, Sweden
11240 DNA vaccine encoding an HIV epitopefused with HBV surface antigen
in Rhesus macaques: Role of HIV specific cytotoxicT lymphocytes
Sylvie Leborgne*; M.L. Michel; A.M. Aubertin; 0. Dormont;
Y. Reviere; R. Le Grand, France
11241 Adenovirus-SIV env priming and boosting with a synthetic peptide
polymer from the C4 region of SIV envelope induces strong cellular
immune responses in Macaques
Jean Patterson*; K.M. Alrich; F.A. Robey; M. Robert-Guroff, USA
11242 Kinetics and persistence of CTL response in macaques and mice
injected with alvac-HIV (vCP205)
Catherine Caillet*; S. Desforges; E. Trannoy, France
11243 CTL induction in macaques using intravenous injection of
autologous PBMCs ex vivo infected with a recombinant
canarypox virus
Catherine Callet*; T.M. Jourdier; JC. Moulin; R. El Habib; E. Trannoy,
France
11244 AIDS induction in Rhesus monkeys with a mutant SHIV by systemic
or mucosal inoculations
Yichen Lu*; D.C. Pauza; N. Letvin; J. Sodroski; CJ. Miller, USA

Track B: Clinical Science and Care
12101 Extended benefit of protease inhibitor-containing combination
therapy through a dissociated viremia-CD4 T cell response
Daniel Kaufmann*; Giuseppe Pantaleo; Pascal Meylan; Philippe Sudre;
Patrick Francioli; Micheal P. Glauser; Amalio Telenti, Switzerland
12102 Change in renal function associated with indinavir
Karim Boubaker*; Frank Bally; Grard Vogel; Jean Yves Meuwly;
Michel P. Glauser; Amalio Telenti, Switzeland
12103 Evaluation of an orphan support programme in RuralTanzania
Peris Lucas Urasa, Tanzania
12104 Reduced mortality across Europe in patients infected with HIV:
Results from the EUROSIDA study
Thomas Benfield*; S. Mocroft; S. Vella; A. Chiesi; V. Miller; J. Kosmiosis;
A.N. Phillips;J.D. Lundgren, Denmark
12105 Homozygous 32 basepair deletion in the C-C chemokine
receptor 5 (CCR5) gene in an HIV-1-infected patient
Hans Heiken*; S. Becker; M. Stoll; I. Batisch; R.E. Schimidt, Germany
12106 Impact ofantiretroviral therapy on the prognostic value
of CD4 cell counts:The EuroSIDA study
Jens D. Lundgren*; Veronica Miller; A. Mocroft; G. Stergiou; P. Reiss;
T Katzenstein;J. van Lunzen; A.N. Phillips, Denmark
12107 HIV/AIDS knowledge, attitudes and practices of community-based
primary care physicians in NewYork City
Wafaa EI-Sadr*; H. Baldwin; E. Wilson; C. Francis, USA
12108 Effect ofcoinfection with HIV and HBV on the progression to AIDS and
death. Evidence from the HIV-ltalian seroconversion study
Maria Barbara Alliegro*; A. Cozzilepri; A. Sinicco; P. Pezzotti;
G. Rezza, Italy
12109 Lack of evidence that b-chemokines are involved in the control of HIV
replication in vivo
Karl-Anton Kreuzer*; J.K. Rockstrom; B. Kupfer; U. Spengler, FRG
12110 Role of CCR5D32 and CCR2-64i Heterozygosities in the Pathogenesis of
HIV-1 Infection
A. Soriano*; E. Palou; T. Gallart; F. Garcia; J.M. Mirb; J. Alcami;
A. Cruceta; J.M. Gatell, Spain
12111 HIV patients'survival in Mexico City:The importance of prophylaxis
and antiviral treatment
M. Sigfrido Rangel-Frausto*; S. Ponce-de-Leon; A. Villasis Kiever;
G.M. Ruiz-Palacios, Mexico
12112 Late potentials-based on instantaneous heart rate histogram in HIVpositive individuals
Paulo Roberto B: Barbosa*; C.A. Morais-de-Sd; J. Barbosa-Filho;
F.S. Sion; I.F.C. Pinto; J. Nadal, Brazil
12113 CD4+ lymphocyte counts and HIV disease progression in subjects coinfected with HIV-1 and HTLV-2
Winston Frederick*; Leleka Doonquah; R.A. Delepeha; L.C. Alexis;
PL. Sappington;J.I. McNeil; W.RJ. Frederick, USA
12114 Safety and efficacy of reduced doses of ritonavir (RTV) plus saquinavir
(SQV) in the treatment of AIDS patients, in Brazil
Carlos Brites*; A.P. A/cdntara; A. Gimbo; N. Silva; C. Pedroso; D. Pedral
Sampalo, Brazil

26

12th World AIDS Conference Geneva